Parkside Financial Bank & Trust Myriad Genetics Inc Transaction History
Parkside Financial Bank & Trust
- $742 Million
- Q4 2024
A detailed history of Parkside Financial Bank & Trust transactions in Myriad Genetics Inc stock. As of the latest transaction made, Parkside Financial Bank & Trust holds 97 shares of MYGN stock, worth $1,203. This represents 0.0% of its overall portfolio holdings.
Number of Shares
97
Previous 104
6.73%
Holding current value
$1,203
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding MYGN
# of Institutions
244Shares Held
91.2MCall Options Held
100KPut Options Held
34K-
Black Rock Inc. New York, NY15.2MShares$188 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.3MShares$128 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA6.72MShares$83.4 Million0.03% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.18MShares$64.2 Million0.07% of portfolio
-
State Street Corp Boston, MA4.7MShares$58.4 Million0.01% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $1B
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...